Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
03/29/2012 | US20120076735 Nanoparticles for Extravascular Administration |
03/29/2012 | US20120076733 Post-biopsy cavity treatment implants and methods |
03/29/2012 | US20120076730 Peptides for transport of therapeutics and their carriers in mouse models and humans |
03/29/2012 | US20120076723 Devices and methods for the treatment of cancer |
03/29/2012 | US20120074614 Systems, methods and apparatuses for manufacturing dosage forms |
03/29/2012 | US20120074026 Pharmaceutical foam |
03/29/2012 | US20120074014 Product typically based on salt of peroxymonosulfuric acid and suitable for medicinal usage, and associated product fabrication |
03/29/2012 | DE202007019385U1 Pharmazeutische Zusammensetzungen, umfassend Clopidogrel Pharmaceutical compositions comprising clopidogrel |
03/29/2012 | CA2849382A1 Therapeutic applications of smad7 |
03/29/2012 | CA2815568A1 Method and system for forming a pharmaceutical product directly onto a packaging surface |
03/29/2012 | CA2812570A1 Controlled release formulations of opioids |
03/29/2012 | CA2812372A1 Pharmaceutical compositions for calanolides, their derivatives and analogues, and process for producing the same |
03/29/2012 | CA2812299A1 Administration of serine protease inhibitors to the stomach |
03/29/2012 | CA2812263A1 Corticosteroid particles and method of production |
03/29/2012 | CA2812208A1 Synthesis of fluorescent noble metal nanoparticles |
03/29/2012 | CA2811919A1 Oral composition and method of forming and using same |
03/29/2012 | CA2811634A1 Antidiabetic solid pharmaceutical compositions |
03/29/2012 | CA2810837A1 Manufacture of tablets from energy-applied powder blend |
03/29/2012 | CA2810623A1 Manufacture of variable density dosage forms utilizing radiofrequency energy |
03/29/2012 | CA2810112A1 Caspofungin composition |
03/29/2012 | CA2809858A1 Novel low molecular weight cationic lipids for oligonucleotide delivery |
03/29/2012 | CA2809646A1 5.alpha.-androstane-3.beta.,5,6.beta.-triol injection and preparation method therefor |
03/29/2012 | CA2809509A1 Pharmaceutical formulations containing rifaximin, processes for their obtainment and method of treating intestinal disease |
03/29/2012 | CA2809050A1 Multi-layered orally disintegrating tablet and the manufacture thereof |
03/29/2012 | CA2780785A1 Pharmaceutical composition having antimicrobial and anti-inflammatory activity for parenteral administration, process for preparing same |
03/29/2012 | CA2780771A1 Pharmaceutical composition having antimicrobial and fast-healing activity for external administration, process for preparing sames |
03/28/2012 | EP2433939A1 Substituted 8-sulfonyl-2,3,4,5-tetrahydro-1h-gamma-carbolines, ligands and pharmaceutical composition; method for the production and use of same |
03/28/2012 | EP2433652A1 Dry-coated orally-disintegrating tablet |
03/28/2012 | EP2433630A1 Self-emulsifying composition of 3 fatty acid |
03/28/2012 | EP2433624A1 Use of buparvaquone for controlling mites parasitising honeybees |
03/28/2012 | EP2433621A1 Rapidly disintegrating dosage form |
03/28/2012 | EP2433620A1 Zibotentan Composition |
03/28/2012 | EP2433619A1 Novel antitumoral agent and its therapeutic uses |
03/28/2012 | EP2433618A1 Easy-disintegrating polymeric micelle composition |
03/28/2012 | EP2432553A2 Liquid dosage forms of isotretinoin |
03/28/2012 | EP2432550A1 Device and methods for enhanced multi-delivery of biologically active substances into an organism and to prevent local irritation |
03/28/2012 | EP2432498A1 A method for keeping an immunogenic composition available for administration to an animal |
03/28/2012 | EP2432492A2 Application and uses of prg4 and therapeutic modulation thereof |
03/28/2012 | EP2432483A1 Composition comprising the purified extract of bee venom for preventing and treating degenerative brain diseases |
03/28/2012 | EP2432479A1 Extended acting oxygen generating composition for treating microbial infections |
03/28/2012 | EP2432462A2 Endoxifen methods and compositions in the treatment of mammalian diseases |
03/28/2012 | EP2432460A1 Water dispersible glyceryl monooleate magnetic nanoparticle formulation |
03/28/2012 | EP2432459A2 Oral compositions of celecoxib |
03/28/2012 | EP2432458A2 Ingestible event markers comprising an ingestible component |
03/28/2012 | EP2432457A1 Stable pharmaceutical composition of fludarabine phosphate |
03/28/2012 | EP2432456A1 Solid pharmaceutical compositions and processes for their production |
03/28/2012 | EP2432455A2 Composition comprising oil drops |
03/28/2012 | EP2432454A1 Compositions for continuous administration of dopa decarboxylase inhibitors |
03/28/2012 | EP2432453A2 Topical retinoid solutions |
03/28/2012 | EP2432452A1 Pharmaceutical oral telmisartan solution |
03/28/2012 | EP2432451A2 Compositions for the treatment of metastatic cancer and methods of use thereof |
03/28/2012 | EP2432450A2 Single-use, disposable strip for application of topical compositions |
03/28/2012 | EP2432444A1 Oral compositions containing polyguanidinium compounds and methods of manufacture and use thereof |
03/28/2012 | EP2432437A2 Dual and single layer dosage forms |
03/28/2012 | EP2432322A1 Optimal compositions and methods for treating oral disease and pain |
03/28/2012 | EP2337580B1 Stabilized compositions for recombinantly produced factor viii |
03/28/2012 | EP2095825B8 Method for treating human diseases associated with an increased deoxyribonucleic acid content in extracellular spaces of tissues and a medicinal preparation for carrying out said method |
03/28/2012 | EP1765894B1 Novel temperature and ph sensitive copolymers |
03/28/2012 | EP1663175B1 Oral drug delivery system |
03/28/2012 | EP1543830B1 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides |
03/28/2012 | EP1476531B1 Scented polymer capsules and the production thereof |
03/28/2012 | EP1465688B9 Bicarbonate-based solutions for dialysis therapies |
03/28/2012 | EP1453508B1 Tempamine compositions and use against cellular oxidative damage |
03/28/2012 | EP1343548B1 Method and apparatus for delivery of therapeutic from a delivery matrix |
03/28/2012 | EP1284711B2 Process for making a blister package containing topiramate tablets |
03/28/2012 | EP1272197B2 Combination of lecithin with ascorbic acid |
03/28/2012 | EP0877562B2 Water dispersible compositions containing natural hydrophilic, water-insoluble pigments, methods of preparing same and their use |
03/28/2012 | CN202173613U 一种防卷边强透气的水杨酸苯酚贴膏 An anti-curling strong breathable salicylic acid phenol Plaster |
03/28/2012 | CN202173612U 鹿角灵芝纳米胶囊 Antlers Ganoderma nanocapsules |
03/28/2012 | CN202173611U 一种新型片剂 A new tablet |
03/28/2012 | CN1954862B Syrup for treating headache |
03/28/2012 | CN1939471B Wuji Baifeng dispersing tablet |
03/28/2012 | CN1939430B Dispersing tablets for clearing heat,purging fire and detoxifying |
03/28/2012 | CN1893892B Pharmaceutical formulations of camptothecins and process for making same |
03/28/2012 | CN1762341B Salvianolic acid compound for treating cardiovascular and cerebrovascular disease and liver disease, and application thereof |
03/28/2012 | CN102395401A Drug delivery through hydrogel plugs |
03/28/2012 | CN102395373A Method for on-demand contraception |
03/28/2012 | CN102395367A Use of nifuratel to treat infections caused by atopobium species |
03/28/2012 | CN102395362A Sublingual spray formulation comprising dihydroartemesinin |
03/28/2012 | CN102395361A Bioavailable capsule compositions of amorphous alpha-(n-sulfonamido)acetamide compound |
03/28/2012 | CN102395360A Precompacted fast-disintegrating formulations of compounds with a low oral bioavailability |
03/28/2012 | CN102395359A Treating alzheimer's disease and osteoporosis and reducing aging |
03/28/2012 | CN102395358A Uses of nk receptor antagonists |
03/28/2012 | CN102395357A Nanofabricated membrane using polymerized proteoliposomes |
03/28/2012 | CN102395356A Ph-modulated formulations for pulmonary delivery |
03/28/2012 | CN102395355A Particle size-structured parenteral dispersions |
03/28/2012 | CN102395354A Microneedle array using porous substrate and process for producing same |
03/28/2012 | CN102391537A Multilayer aquagel, and preparation method and application thereof |
03/28/2012 | CN102391517A Nanometer micelle capable of intelligently releasing medicine as well as preparation method and application thereof |
03/28/2012 | CN102391429A PH-sensitive xylan hydrogel and preparation method thereof |
03/28/2012 | CN102391188A Ornidazole hydrate crystal, preparation method thereof and crystal-containing composition tablets |
03/28/2012 | CN102389573A Medicament for treating malignant glioma and preparation method thereof |
03/28/2012 | CN102389572A Chitosan-carboxylated chitosan nanosphere loading insoluble antitumor drug and preparation method and application thereof |
03/28/2012 | CN102389571A Medicine sustained-release suppository used for in-vivo injection |
03/28/2012 | CN102389563A Transdermal absorption traditional Chinese medicinal blood pressure protection bag and its preparation method |
03/28/2012 | CN102389557A Chinese medicinal composition and Chinese medicinal ball for treating uterine cancer and application thereof |
03/28/2012 | CN102389556A Chinese medical drug abstinence tablet and preparation process thereof |
03/28/2012 | CN102389540A Calcium gluconate oral solution with effect of strengthening the spleen and stomach |
03/28/2012 | CN102389539A Pure traditional Chinese medicine preparation for removing speckle and beautifying, and preparation method of pulvis and particle of the preparation |
03/28/2012 | CN102389538A Traditional Chinese medicine capsule preparation for treating nasopharyngitis |